USA flag logo/image

An Official Website of the United States Government

NOVEL AGENT TO RESTORE SENSITIVITY TO ANTI-ESTROGEN THERAPY

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
Program Year/Program:
2012 / SBIR
Agency Tracking Number:
N43CO120060
Solicitation Year:
2012
Solicitation Topic Code:
NCI
Solicitation Number:
Small Business Information
A AND G PHARMACEUTICAL, INC.
A AND G PHARMACEUTICAL, INC. 9130 RED BRANCH RD, STE U COLUMBIA, MD 21045-
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 2012
Title: NOVEL AGENT TO RESTORE SENSITIVITY TO ANTI-ESTROGEN THERAPY
Agency: HHS
Contract: N43CO120060
Award Amount: $199,380.00
 

Abstract:

Aromatase Inhibitors (AI) are the preferred hormonal treatment for estrogen receptor positive Breast Cancer (BC) in postmenopausal women and are used to treat approximately 140,000 patients annually in the US. However, ~40% of patients will be, or become resistant to AIs. If sensitivity to AI can be re-established in patients that have become resistant, this would be a major step forward in treating ER+ BC patients. The PI has characterized a growth factor, GP88, and demonstrated its critical role in the development, proliferation and survival of cancer cells. Importantly, the PI has demonstrated using in vitro studies that GP88 is a driver in controlling cancer cell resistance to AIs such as Letrozole. The PI has developed a neutralizing monoclonal anti-GP88 antibody, shown in vitro to return BC cell sensitivity to AIs in previously AI resistant cell lines. This application seeks to prove through the use of xenograft studies that anti-GP88 is effective in vivo in restoring AI sensitivity in previously resistant tumors. If successful, anti-GP88 in conjunction with AI therapy in AI resistant patients would be a major advancement in treating BC patients that currently have systemic chemotherapy as their only option and could improve overall BC survival.

Principal Investigator:

Ginette P. Serrero
410-884-4100
GSERRERO@AGPHARMA.COM

Business Contact:

Ginette P. Serrero
410-884-4100
GSERRERO@AGPHARMA.COM
Small Business Information at Submission:

A AND G PHARMACEUTICAL, INC.
A AND G PHARMACEUTICAL, INC. 9130 RED BRANCH RD, STE U COLUMBIA, MD 21045-

EIN/Tax ID: 522250475
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No